Activity of cetuximab as single agent in a patient with relapsed multiple myeloma

Leuk Lymphoma. 2010 Mar;51(3):562-4. doi: 10.3109/10428190903580428.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / pharmacology*
  • Cetuximab
  • ErbB Receptors / metabolism
  • Humans
  • Immunoglobulin G / metabolism
  • Ligands
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Recurrence
  • Remission Induction
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Immunoglobulin G
  • Ligands
  • ErbB Receptors
  • Cetuximab